<!DOCTYPE html>
<html>
    <head>
        <title>ONALABS QMS : OV E5.5. Risk Assessment and Evaluation</title>
        <link rel="stylesheet" href="styles/site.css" type="text/css" />
        <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    </head>

    <body class="theme-default aui-theme-default">
        <div id="page">
            <div id="main" class="aui-page-panel">
                <div id="main-header">
                    <div id="breadcrumb-section">
                        <ol id="breadcrumbs">
                            <li class="first">
                                <span><a href="index.html">ONALABS QMS</a></span>
                            </li>
                                                    <li>
                                <span><a href="OV-ONAVITAL-MDR-Product-Technical-File_3342337.html">OV ONAVITAL MDR Product Technical File</a></span>
                            </li>
                                                    <li>
                                <span><a href="3342756.html">OV Part E: Risk Management Files</a></span>
                            </li>
                                                </ol>
                    </div>
                    <h1 id="title-heading" class="pagetitle">
                                                <span id="title-text">
                            ONALABS QMS : OV E5.5. Risk Assessment and Evaluation
                        </span>
                    </h1>
                </div>

                <div id="content" class="view">
                    <div class="page-metadata">
                            
        
    
        
    
        
        
            Created by <span class='author'> Richard Bunney</span>, last modified by <span class='editor'> Jaime Punter</span> on May 20, 2025
                        </div>
                    <div id="main-content" class="wiki-content group">
                    <p><span class="status-macro aui-lozenge aui-lozenge-visual-refresh aui-lozenge-error">COMPANY CONFIDENTIAL</span> <span class="status-macro aui-lozenge aui-lozenge-visual-refresh aui-lozenge-error">UNCONTROLLED IF PRINTED</span></p><p>Owner: Jaime Punter, CTO and Quality Representative</p><p>Â </p><div class="ap-container" id="ap-com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6902566641627086523">

  <div class="ap-content " id="embedded-com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6902566641627086523"></div>
  <script nonce="528a568c4bd9f0fff5a3a25050ba0fb5" class="ap-iframe-body-script">
  (function(){
    var data = {
    "addon_key":"com.automation-consultants.accloud.approvalmacro",
    "uniqueKey":"com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6902566641627086523",
    "key":"ApprovalsStatusMacro",
     "moduleType":"dynamicContentMacros",      "moduleLocation":"content",         "cp":"/wiki",
            "general":"",
    "w":"",
    "h":"",
    "url":"https://ac-cloud.com/approvalmacro/macro/page-status/display?xdm_e=https%3A%2F%2Fonalabs.atlassian.net&xdm_c=channel-com.automation-consultants.accloud.approvalmacro__ApprovalsStatusMacro6902566641627086523&cp=%2Fwiki&xdm_deprecated_addon_key_do_not_use=com.automation-consultants.accloud.approvalmacro&lic=active&cv=1000.0.0-c58bc7260813&traceId=c43dc756f82ca2f0cdca1f55fd01907f&spanId=a5e3efe69e23a77f&traceSampled=0&jwt=eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWIiOiI2MDU0OTY2Yjk0ZDdiOTAwNjkwMmRkMWUiLCJxc2giOiJmMDAxYTA0ZGQwZmUwOTBjYzNmNjMwOGY5YWU3MDE1YjdjMGJjZGQ3MGE5ODZmY2MyMDdjZDlmZjM4MDViM2E3IiwiaXNzIjoiNzdjODA3YTAtMmNjNy0zZWVjLWEzNDItOWQzYzYyZjUwZWE0IiwiY29udGV4dCI6e30sImV4cCI6MTc1MTI5NTU4MSwiaWF0IjoxNzUxMjk1NDAxfQ.rGZjbKQvEKgPJlBbg2CD67NRZVmdf9REf_UCFrq52pE",
     "contextJwt": "eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.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.9xBjrEifmYK0SagAgSh-cSo3K8OfWsZ21T5RHEtv888",    "structuredContext": "{\"license\":{\"active\":true},\"confluence\":{\"editor\":{\"version\":\"v2\"},\"macro\":{\"outputType\":\"html_export\",\"hash\":\"5b3f4c99-fd37-4736-8505-6fcfada165d8\",\"id\":\"5b3f4c99-fd37-4736-8505-6fcfada165d8\"},\"tracing\":{\"traceId\":\"c43dc756f82ca2f0cdca1f55fd01907f\",\"spanId\":\"a5e3efe69e23a77f\",\"sampled\":\"0\"},\"content\":{\"type\":\"page\",\"version\":\"27\",\"id\":\"3342773\"},\"space\":{\"key\":\"ONALABSQMS\",\"id\":\"2752512\"}},\"url\":{\"displayUrl\":\"https://onalabs.atlassian.net/wiki\"}}",
    "contentClassifier":"content",
    "productCtx":"{\"page.id\":\"3342773\",\"macro.hash\":\"5b3f4c99-fd37-4736-8505-6fcfada165d8\",\"space.key\":\"ONALABSQMS\",\"tracing.sampled\":\"0\",\"page.type\":\"page\",\"content.version\":\"27\",\"page.title\":\"OV E5.5. Risk Assessment and Evaluation\",\"macro.localId\":\"8f74d0e1-dbae-4d95-8173-5baea32ae9bb\",\"macro.body\":\"\",\": = | RAW | = :\":null,\"space.id\":\"2752512\",\"macro.truncated\":\"false\",\"content.type\":\"page\",\"output.type\":\"html_export\",\"page.version\":\"27\",\"macro.fragmentLocalId\":\"\",\"content.id\":\"3342773\",\"tracing.traceId\":\"c43dc756f82ca2f0cdca1f55fd01907f\",\"macro.id\":\"5b3f4c99-fd37-4736-8505-6fcfada165d8\",\"tracing.spanId\":\"a5e3efe69e23a77f\",\"user.isExternalCollaborator\":\"false\",\"editor.version\":\"v2\"}",
    "timeZone":"GB",
    "origin":"https://ac-cloud.com",
    "hostOrigin":"https://onalabs.atlassian.net",
    "sandbox":"allow-downloads allow-forms allow-modals allow-popups allow-popups-to-escape-sandbox allow-scripts allow-same-origin allow-top-navigation-by-user-activation allow-storage-access-by-user-activation",    "pearApp":"true",        "apiMigrations": {
        "gdpr": true
    }
}
;
    if(window.AP && window.AP.subCreate) {
      window._AP.appendConnectAddon(data);
    } else {
      require(['ac/create'], function(create){
        create.appendConnectAddon(data);
      });
    }

    // For Confluence App Analytics. This code works in conjunction with CFE's ConnectSupport.js.
    // Here, we add a listener to the initial HTML page that stores events if the ConnectSupport component
    // has not mounted yet. In CFE, we process the missed event data and disable this initial listener.
    const __MAX_EVENT_ARRAY_SIZE__ = 20;
    const connectAppAnalytics = "ecosystem.confluence.connect.analytics";
    window.connectHost && window.connectHost.onIframeEstablished((eventData) => {
      if (!window.__CONFLUENCE_CONNECT_SUPPORT_LOADED__) {
        let events = JSON.parse(window.localStorage.getItem(connectAppAnalytics)) || [];
        if (events.length >= __MAX_EVENT_ARRAY_SIZE__) {
          events.shift();
        }
        events.push(eventData);
        window.localStorage.setItem(connectAppAnalytics, JSON.stringify(events));
      }
    });

  }());
</script>

</div>
<h3 id="OVE5.5.RiskAssessmentandEvaluation-1.Purpose">1. Purpose </h3><p>To develop risk management spreadsheets logs that record the various risks and mitigation factors that are uncovered and mitigated as the project and product evolve.</p><h3 id="OVE5.5.RiskAssessmentandEvaluation-2.Scope">2. Scope</h3><p>The Risk Assessment and Evaluation is constructed in alignment with and applies the good practice principles of ISO14971:2019.</p><h3 id="OVE5.5.RiskAssessmentandEvaluation-3.Relevantinformation">3. Relevant information</h3><p>Risk Management Procedures found here: <a href="https://onalabs.atlassian.net/wiki/spaces/ONALABSQMS/pages/2753516/OLQMS-PRO003+-+Risk+Management+SOP" data-linked-resource-id="2753516" data-linked-resource-version="17" data-linked-resource-type="page">OLQMS-PRO003 - Risk Management SOP</a> </p><p>Risk Management Plan found here: <a href="OV-E5.1.-Risk-Management-Plan_33816587.html" data-linked-resource-id="33816587" data-linked-resource-version="8" data-linked-resource-type="page">OV E5.1. Risk Management Plan</a> </p><p>Initial Hazard Analysis: <a href="OV-E5.2.-Initial-Hazard-Analysis_91258881.html" data-linked-resource-id="91258881" data-linked-resource-version="12" data-linked-resource-type="page">OV E5.2. Initial Hazard Analysis</a> </p><p>Failure Mode Effects Analysis (FMEA): <a href="91783190.html" data-linked-resource-id="91783190" data-linked-resource-version="7" data-linked-resource-type="page">OV E5.4. Failure Mode Effect &amp; Analysis</a> </p><h3 id="OVE5.5.RiskAssessmentandEvaluation-4.RiskManagementSpreadsheet">4. Risk Management Spreadsheet</h3><div class="table-wrap"><table data-table-width="1800" data-layout="full-width" data-local-id="a74a5388-2fdc-4027-b5f4-fe86656cc596" class="confluenceTable"><colgroup><col style="width: 167.0px;"/><col style="width: 156.0px;"/><col style="width: 119.0px;"/><col style="width: 117.0px;"/><col style="width: 102.0px;"/><col style="width: 144.0px;"/><col style="width: 122.0px;"/><col style="width: 237.0px;"/><col style="width: 187.0px;"/><col style="width: 223.0px;"/><col style="width: 226.0px;"/></colgroup><tbody><tr><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Risk Scenario</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Patient Impact</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Risk Source</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Severity (1-5)</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Probability (1-5)</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Risk Estimation Assessment</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Residual Risk</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Main stakeholder affected</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Scenario where this risk could arise</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Potential Mitigations</strong></p></td><td data-highlight-colour="#f4f5f7" class="confluenceTd"><p><strong>Actual Mitigations</strong></p></td></tr><tr><td class="confluenceTd"><p>Client Availability</p></td><td class="confluenceTd"><p>---</p></td><td class="confluenceTd"><p>Commercial</p></td><td class="confluenceTd"><p>3</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Onalabs</p></td><td class="confluenceTd"><p>Poor post-market assistance.</p></td><td class="confluenceTd"><p>Communication with client  team to solve issue.</p></td><td class="confluenceTd"><p>PMCF (Post-Market Clinical Follow-up) and PSUR (Periodic Safety Update Report)</p></td></tr><tr><td class="confluenceTd"><p>Scalability issues</p></td><td class="confluenceTd"><p>---</p></td><td class="confluenceTd"><p>Commercial</p></td><td class="confluenceTd"><p>3</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Onalabs</p></td><td class="confluenceTd"><p>Poor supplier agreements. Poor cost-effectiveness.</p></td><td class="confluenceTd"><p>Scalability by design.</p></td><td class="confluenceTd"><p>We have selected key suppliers and have agreed on a Quality Agreement.</p></td></tr><tr><td class="confluenceTd"><p>Product produces sensitisation / irritation / Pain</p></td><td class="confluenceTd"><p>Patient can experience discomfort, making it do not use the device or producing skin irritation.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation </p></td><td class="confluenceTd"><p>Product materials are not suitable / medical grade.</p><p>Poor biocompatibility testing.</p></td><td class="confluenceTd"><p>Raw materials have been specifically chosen to alliviate this issue (materials already tested for biocompatibility according to ISO 10993-1  test requirements). QC (testing) checks at all stages of manufacture</p></td><td class="confluenceTd"><p>Biocompatibility test will be made.</p></td></tr><tr><td class="confluenceTd"><p>Accidental damage</p></td><td class="confluenceTd"><p>Patient can not use the device due to damage. Vital signs will not be measured.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>4</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation </p></td><td class="confluenceTd"><p>Product materials are not suitable / robust.</p><p>Poor shock and vibration testing.</p></td><td class="confluenceTd"><p>Housing design (materials and design) and manufacturing have been done for structural robustness.</p></td><td class="confluenceTd"><p>Shock and vibration tests will be made.</p></td></tr><tr><td class="confluenceTd"><p>Product performance impacted by poor maintenance / cleaning</p></td><td class="confluenceTd"><p>Patient Vital Signs measurements can be impacted, providing an erroneous understanding of the physiological status of the patient to all stakeholders. In extreme cases damage will be done to the Device.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation </p></td><td class="confluenceTd"><p>Product is not well maintained.</p></td><td class="confluenceTd"><p>Product do not need exhausitive maintenance / cleaning.</p></td><td class="confluenceTd"><p>Instructions for Use and user manual guidance provide information about product cleaning.</p></td></tr><tr><td class="confluenceTd"><p>Poor quality user data</p></td><td class="confluenceTd"><p>Patient Vital Signs measurements do not correctly reflect the reality, providing an erroneous understanding of the physiological status of the patient to all stakeholders.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>3</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation </p></td><td class="confluenceTd"><p>Product do not provide accurate biometric data. Bad/incorrect algorithm.</p></td><td class="confluenceTd"><p>Development of algorithms and testing/evaluation according to established ISOs. </p></td><td class="confluenceTd"><p>Development of firmware and testing according to established ISOs as it is described on the Documentation.</p></td></tr><tr><td class="confluenceTd"><p>Product does not work</p></td><td class="confluenceTd"><p>All Stakeholders will be affected. Patients can not rely on the Device to correctly function as intended. Harm can be done as it will be difficult for any Stakeholder to recognize this risk.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>4</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation </p></td><td class="confluenceTd"><p>Product do not perform according to the product claims and indications. </p></td><td class="confluenceTd"><p>Development of product have followed a strict development programe with the necessary verification and validation steps.</p></td><td class="confluenceTd"><p>Product have been validated with enough population on proper environments.</p></td></tr><tr><td class="confluenceTd"><p>Product is not properly used/ Product is not user friendly and/or difficult to use for final users</p></td><td class="confluenceTd"><p>Patients can not be able to use the device due to lack of understanding of how to use it. Less harm will be done that in previous cases as all the stakeholders will now the Patient is not using the Device.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation </p></td><td class="confluenceTd"><p>Product it is not properly working due to user faulty use of it. Poor early design.</p></td><td class="confluenceTd"><p>Product have been designed to be as easy to use as possible, with minimal user intervention for proper product performance. Pay special attention to USERS definition during early design, planning and development.</p></td><td class="confluenceTd"><p>Instructions for Use and user manual guidance provide information about product cleaning. In addition, we have co-created ONAVITAL by means of clinical investigations with Hospital Germans Trias i Pujol, as well as doing co-creation sessions with KOLs and select stakeholders.</p></td></tr><tr><td class="confluenceTd"><p>Unclear or incomplete use cases / user info</p></td><td class="confluenceTd"><p>Some Patients can not be able to use the device due to lack of understanding of how to use it.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation (eg financial data)</p></td><td class="confluenceTd"><p>Poor early design.</p></td><td class="confluenceTd"><p>Co-creation methodology for early design, planning and development.</p></td><td class="confluenceTd"><p>We have co-created ONAVITAL by means of clinical investigations with Hospital Germans Trias i Pujol, as well as doing co-creation sessions with KOLs and select stakeholders.</p></td></tr><tr><td class="confluenceTd"><p>Delay suppliers and / or scarce of technological components</p></td><td class="confluenceTd"><p>---</p></td><td class="confluenceTd"><p>Commercial</p></td><td class="confluenceTd"><p>2</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Onalabs/patient/professional/ organisation </p></td><td class="confluenceTd"><p>Product development and manufacturing.</p></td><td class="confluenceTd"><p>Product have been designed taking into account replaceable and/or family based off-the-shelf products.</p></td><td class="confluenceTd"><p>We have selected key suppliers and have agreed on a Quality Agreement.</p></td></tr><tr><td class="confluenceTd"><p>User application flashed into the microcontroller contains errors or bugs</p></td><td class="confluenceTd"><p>Malfunction of the device not complying with the functional requirements expected by the patient. Examples may include receiving non-periodic measurements or not receiving measurements, or receiving measurements with out-of-specification accuracy.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>3</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation </p></td><td class="confluenceTd"><p>Error in the execution of the validation process of the acceptance criteria in any of the device requirements.</p></td><td class="confluenceTd"><p>Replace the devices with the user application with errors by others with the device with the new user application.</p><p>Request the devices with the user application with errors, program the new user application and return them.</p><p>Remotely update the user application of the devices with the new version via over-the-air (OTA) update.</p></td><td class="confluenceTd"><p>Over-the-air update functionality is provided in the device.</p></td></tr><tr><td class="confluenceTd"><p>Malicious installation of a fraudulent user application update via over-the-air</p></td><td class="confluenceTd"><p>All Stakeholders will be affected. Patients can not rely on the Device to correctly function as intended. Harm can be done as it will be difficult for any Stakeholder to recognize this risk.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>4</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation</p></td><td class="confluenceTd"><p>Poor early design.</p></td><td class="confluenceTd"><p>Check the authenticity of the update file.</p></td><td class="confluenceTd"><p>Sign the update files using an asymmetric key and, when an update is performed, the device checks the authenticity of the signature in order to proceed with the installation of the update.</p></td></tr><tr><td class="confluenceTd"><p>An attacker who intercepts or gets hold of an update file can access the contents of the file and reverse engineer it to obtain the user application.</p></td><td class="confluenceTd"><p>---</p></td><td class="confluenceTd"><p>Commercial</p></td><td class="confluenceTd"><p>4</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Onalabs</p></td><td class="confluenceTd"><p>Poor early design.</p></td><td class="confluenceTd"><p>Encrypt the update file to protect its contents.</p></td><td class="confluenceTd"><p>Encrypt the file with a symmetric key and, when the device receives the update file, decrypt it.</p></td></tr><tr><td class="confluenceTd"><p>The update file has been modified due to communication errors or a malicious modification by an attacker.</p></td><td class="confluenceTd"><p>All Stakeholders will be affected. Patients can not rely on the Device to correctly function as intended. Harm can be done as it will be difficult for any Stakeholder to recognize this risk.</p></td><td class="confluenceTd"><p>Product</p></td><td class="confluenceTd"><p>4</p></td><td class="confluenceTd"><p>1</p></td><td class="confluenceTd"><p>Low</p></td><td class="confluenceTd"><p>Acceptable</p></td><td class="confluenceTd"><p>Patient/professional/ organisation</p></td><td class="confluenceTd"><p>Poor early design.</p></td><td class="confluenceTd"><p>Attach a hash to the update file to verify that the update file has not been modified.</p></td><td class="confluenceTd"><p>A hash of the update file is generated and incorporated into the update file, and, when the device receives the update file, it recalculates the hash and checks that it is the same as the hash sent with the update file.</p></td></tr></tbody></table></div><h3 id="OVE5.5.RiskAssessmentandEvaluation-5.DocumentDistribution">5. Document Distribution</h3><div class="table-wrap"><table data-table-width="760" data-layout="default" data-local-id="d51499c6-f4f8-406e-8c0b-d1c031ce9c97" class="confluenceTable"><colgroup><col style="width: 380.0px;"/><col style="width: 380.0px;"/></colgroup><tbody><tr><td class="confluenceTd"><p>Â </p></td><td class="confluenceTd"><p>Action/ information</p></td></tr><tr><td class="confluenceTd"><p>This document is intended for an internal and (restricted) external audience.</p><p>The external audience may include the following organisations and regulators:</p><ul><li><p>Approved Bodies: conformity assessment bodies for the Medical Device Regulations.</p></li><li><p>Certification Body responsible for auditing and certifying the Quality Management System (QMS) to ISOÂ 13485Â </p></li><li><p>Third party contractors and suppliers involved in the manufacture</p></li></ul><p>All external distribution of this document must be approved prior to circulation.</p></td><td class="confluenceTd"><p>Information</p><p>Â </p></td></tr></tbody></table></div><p>Â </p>
                    </div>

                                        <div class="pageSection group">
                        <div class="pageSectionHeader">
                            <h2 id="attachments" class="pageSectionTitle">Attachments:</h2>
                        </div>

                        <div class="greybox" align="left">
                                                            <img src="images/icons/bullet_blue.gif" height="8" width="8" alt=""/>
                                <a href="attachments/3342773/3342782.png">image-20210726-105018.png</a> (image/png)
                                <br/>
                                                    </div>
                    </div>
                    
                                                      
                </div>             </div> 
            <div id="footer" role="contentinfo">
                <section class="footer-body">
                    <p>Document generated by Confluence on Jun 30, 2025 15:56</p>
                    <div id="footer-logo"><a href="http://www.atlassian.com/">Atlassian</a></div>
                </section>
            </div>
        </div>     </body>
</html>
